Changchun High-tech: The company is currently focusing on core resources to promote the sale of new products such as Jin Beixin and Meisiya.

Changchun High-tech expressed in a telephone conference that in the first three quarters, the sales of Golden Race Pharmaceuticals' core products have remained relatively stable, with the proportion of revenue from long-acting growth hormone products further increasing; at the same time, progress in new business areas is significant. The company is focusing its core resources on promoting the sales of new products such as Jinbeixin and Meisiya, aiming to cultivate these new products as new profit growth points for the company.